Industry Sponsor Influence in Clinical Trial Reporting in Canada: A Qualitative Interview Study

•Industry sponsors in some cases influence decisions on whether to report trials.•Companies may influence reporting through owning and controlling access to data.•Trial agreements may only weakly protect the right of site investigators to publish.•Early phase internal company trials are a source of unpublished clinical trials.•Small biotech firms may cease operations without publishing their results.